🇺🇸 FDA
Patent

US 9486401

Use of cellular extracts for skin rejuvenation

granted A61KA61K35/60A61K8/676

Quick answer

US patent 9486401 (Use of cellular extracts for skin rejuvenation) held by REGENICS AS expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/60, A61K8/676, A61K8/982, A61K8/987